Skip to main content
Immune Tolerance Network

Developing, funding and conducting clinical trials in immune tolerance

Share This
Home

A clinical trial for liver transplant recipients

 

OPTIMAL is no longer recruiting study participants

  • Home
  • Liver Transplant Tolerance
  • About OPTIMAL
  • Are You Eligible?
  • Study Locations

OPTIMAL a study for liver transplant recipients

Welcome to the OPTIMAL study

OPTIMAL is a clinical trial for liver transplant recipients that will gradually reduce participants’ anti-rejection medication(s) over a period of time.

The OPTIMAL Study

A clinical trial investigating immunosuppression withdrawal in liver transplant recipients.

Are You Eligible?

OPTIMAL is no longer recruiting study participants.

Study Locations

Find the OPTIMAL Clinical Research Study Site closest to you.

OPTIMAL is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health .

National Institute of Allergy and Infectious Disease

Immune Tolerance Network

  • Home
  • Liver Transplant Tolerance
  • About Optimal
  • Are You Eligible?
  • Study Locations
  • About ITN
  • More ITN Trials
  • Understanding Clinical Trials
  • Patient Rights & Informed Consent
  • ClinicalTrials.gov